Table 4.

Beta-rebound measurements.

A	STN−CONTRA	STN+CONTRA	STN−IPSI	STN+IPSI	STN−CONTRA	STN+IPSI	STN−IPSI	STN+CONTRA	STN−IPSI	STN−CONTRA	STN+IPSI	STN+CONTRA
wue02	49.94	17.62*	43.95	17.33*	49.94	17.33*	43.95	17.62*	43.95	49.94	17.33	17.62
wue05	51.74	16.90*	25.40	19.19	51.74	19.19*	25.40	16.90	25.40	51.74*	19.19	16.90
wue09	64.74	36.20*	48.51	29.74*	64.74	29.74*	48.51	36.20*	48.51	36.20*	29.74	36.20
wue11	63.93	31.75*	37.01	38.57	63.93	38.57*	37.01	31.75	37.01	63.93*	38.57	31.75
B	MC−CONTRA	MC+CONTRA	MC−IPSI	MC+IPSI	MC−CONTRA	MC+IPSI	MC−IPSI	MC+CONTRA	MC−IPSI	MC−CONTRA	MC+IPSI	MC+CONTRA
wue02	32.45	26.84	19.67	22.64	32.45	22.64	19.67	26.84	19.67	32.45*	22.64	26.84
wue05	55.88	57.13	42.54	63.77*	55.88	63.77	42.54	57.13	42.54	55.88	63.77	57.13
wue09	56.76	59.31	31.75	57.39*	56.76	57.39	31.75	59.31*	31.75	56.76*	57.39	59.31
wue11	60.57	34.75*	36.03	63.80*	60.57	63.80	36.03	34.75	36.03	60.57*	63.80	34.75*

Significant differences considering separately the STN (A) and the MC (B) for all the six possible comparisons. Brain structures are distinguished with regards to striatal dopaminergic innervation loss and clinical severity. In each cell, we show the average rebound value, expressed as percentage of relative power change (see also Figure 1 and Figure S6, Supplementary Material, Results). As in Table 3; “IPSI” and “CONTRA” refer to movement performed with the hand ipsilateral or contralateral to the examined STN (STN− or STN+). “−” (MC− and STN−) and “+” (MC+ and STN+) refer instead to the side with less and more striatal dopaminergic innervation or the more and less clinically affected hemibody (for wue05). MC, motor cortex; STN, subthalamic nucleus. *Indicates significance at p < 0.05 between each comparison (e.g., STN−_CONTRA vs. STN+_CONTRA).